Literature DB >> 15767744

Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms.

Laura Cebrián1, Juan Carlos Rodríguez, Isabel Escribano, Gloria Royo.   

Abstract

BACKGROUND: We studied the importance of the efflux pump mechanisms in Salmonella spp. mutants with reduced fluoroquinolone susceptibility generated in vitro.
METHODS: The efflux pump was studied using MC-207,110 as an inhibitor of these systems.
RESULTS: Wild strains with mutations in gyrA exhibit greater activity of the efflux pump systems than nalidixic-acid-susceptible strains (30-fold). When we evaluate the respective mutants, in those of susceptible strains there is seen to be greater elimination of the antibiotic (13-fold), whereas in mutants of nalidixic-acid-resistant strains these systems are not modified. When evaluating the influence of the antibiotic generating the mutants, ciprofloxacin is seen to be the quinolone that activates the efflux pump systems the most.
CONCLUSIONS: Repeated exposure to low concentrations of all the fluoroquinolones studied leads to activation of the efflux pump systems and a reduction in susceptibility, even when there are no mutations in gyrA. Activation of these mechanisms is greatly influenced by the chemical structure of the antibiotic. The capacity of these systems to eliminate fluoroquinolones is limited and therefore, for the microorganism to acquire high-level fluoroquinolone resistance, they must be complemented by other mechanisms. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767744     DOI: 10.1159/000084417

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  4 in total

1.  New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.

Authors:  Antti J Hakanen; Marianne Lindgren; Pentti Huovinen; Jari Jalava; Anja Siitonen; Pirkko Kotilainen
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Prevalence, serovars, phage types, and antibiotic susceptibilities of Salmonella strains isolated from animals in the United Arab Emirates from 1996 to 2009.

Authors:  Sebastian Münch; Peggy Braun; Ulrich Wernery; Jörg Kinne; Michael Pees; Antje Flieger; Erhard Tietze; Wolfgang Rabsch
Journal:  Trop Anim Health Prod       Date:  2012-04-04       Impact factor: 1.559

3.  Molecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in Bangladesh.

Authors:  Samir K Saha; Gary L Darmstadt; Abdullah H Baqui; Derrick W Crook; M Nurul Islam; Maksuda Islam; Maqsud Hossain; Shams El Arifeen; Mathuram Santosham; Robert E Black
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

4.  PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat Staphylococcus aureus-induced skin infections.

Authors:  Minghao Sun; Chune Zhu; Jieyu Long; Chao Lu; Xin Pan; Chuanbin Wu
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.